ALLO peer analysis
Allogene Therapeutics (ALLO) against its competitors: price, today's move, 1-year return and market value side by side.
- ALLO's peers: ATRA (Atara Biotherapeutics), AUTL (Autolus Therapeutics), CELU (Celularity), CLLS (Cellectis), CRBU (Caribou Biosciences), DTIL (Precision BioSciences), FATE (Fate Therapeutics), IPSC (Century Therapeutics).
ALLO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ATRA Atara Biotherapeutics | $6.34 | -6.35% | -53.86% | $64.59M |
| AUTL Autolus Therapeutics | $0.92 | -6.08% | -27.56% | $245.03M |
| CELU Celularity | $0.47 | -3.15% | -72.31% | $15.18M |
| CLLS Cellectis | $0.98 | -4.49% | -77.64% | $99.10M |
| CRBU Caribou Biosciences | $0.30 | -4.86% | -83.77% | $31.91M |
| DTIL Precision BioSciences | $7.40 | 7.09% | 53.53% | $206.72M |
| FATE Fate Therapeutics | $0.96 | -5.06% | -8.68% | $116.57M |
| IPSC Century Therapeutics | $1.16 | -12.46% | 123.54% | $209.84M |
| ALLO Allogene Therapeutics | $0.63 | -4.83% | -49.63% | $219.90M |